Plant-Based Med Shows Promise for Smoking Cessation

More than 20% of smokers who took cytisinicline remained smoke-free up to 3 months after treatment, results from the first large-scale US clinical trial of the drug show.

Related Keywords

Boston ,Massachusetts ,United States ,Illinois ,Chicago ,University Of Chicago ,Jessica Yingst ,Cindy Jacobs ,Anthony Clarke ,Sophiai Allen ,Jonathan Foulds ,Nancy Rigotti ,Daniel Cain ,Andrea King ,Treatment Center At Mass ,Research On Tobacco ,Life Sciences ,Tobacco Research ,Penn State Center ,Johnson ,Harvard Medical School ,National Institutes Of Health ,Penn State College Of Medicine ,Treatment Center ,Mass General Hospital ,Medscape Medical ,Medscape Medical News ,Achieve Life Sciences ,Penn State College ,Eastern European ,Achieve Life ,National Institutes ,